HEALTHEQUITY, INC. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
HealthEquity reported Q2 FY27 (ended July 31, 2026) revenue of $350.7M (+8% YoY), net income of $65.6M (+10% YoY, $0.78/share +15%), and Adjusted EBITDA of $167.0M (+11% YoY, 48% margin vs 46%). HSA Assets grew 14% to $37.9B; HSAs reached record 10.7M accounts (+8% YoY). Company raised FY27 guidance to $1.411–1.421B revenue and $242–248M net income ($2.88–2.96/share). Repurchased 1.2M shares for $108.1M in Q2.
Why this rating
Solid operational beat with margin expansion and strong asset growth; guidance raise signals confidence. Dollar scale modest relative to $7B market cap (~1.5% revenue run-rate quarterly), but sustained 8–14% growth and record margins are meaningful. Not transformational, but solid execution and raised outlook justify moderate weight.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.